Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O H Pearson

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Cancer|February 1, 1979
Antihormone treatment of stage IV breast cancerA Manni, J E Trujillo, J S Marshall, et al.
Endocrinology|August 1, 1982
Hormone dependency in N-nitrosomethylurea-induced rat mammary tumorsB M Arafah, H M Finegan, J Roe, et al.
Journal of Steroid Biochemistry|December 1, 1985
Adjuvant endocrine therapy, cytotoxic chemotherapy and immunotherapy in stage II breast cancer: 6-year resultC A Hubay, O H Pearson, A Manni, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1983
Inhibitory action of bromocriptine and tamoxifen on the growth of human pituitary tumors in soft agarB M Arafah, B L Wilhite, J Rainieri, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1980
Transsphenoidal microsurgery in the treatment of acromegaly and gigantismB U Arafah, J S Brodkey, B Kaufman, et al.
The New England Journal of Medicine|December 1, 1983
Progesterone receptors as a prognostic factor in Stage II breast cancerG M Clark, W L McGuire, C A Hubay, et al.
Surgery|October 1, 1986
The interaction of estrogen receptor status and race in predicting prognosis for stage I breast cancer patientsJ P Crowe, N H Gordon, C A Hubay, et al.
Cancer|November 1, 1989
Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancerO H Pearson, C A Hubay, N H Gordon, et al.
Surgery|October 1, 1987
Recurrence patterns in a prospective study of patients with stage II breast cancer treated with endocrine-chemotherapyJ P Crowe, N H Gordon, A R Antunez, et al.
Breast Cancer Research and Treatment|January 1, 1982
Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsJ P Crowe, C A Hubay, O H Pearson, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cancer|February 1, 1979
Antihormone treatment of stage IV breast cancerA Manni, J E Trujillo, J S Marshall, et al.
Endocrinology|August 1, 1982
Hormone dependency in N-nitrosomethylurea-induced rat mammary tumorsB M Arafah, H M Finegan, J Roe, et al.
Journal of Steroid Biochemistry|December 1, 1985
Adjuvant endocrine therapy, cytotoxic chemotherapy and immunotherapy in stage II breast cancer: 6-year resultC A Hubay, O H Pearson, A Manni, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1983
Inhibitory action of bromocriptine and tamoxifen on the growth of human pituitary tumors in soft agarB M Arafah, B L Wilhite, J Rainieri, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1980
Transsphenoidal microsurgery in the treatment of acromegaly and gigantismB U Arafah, J S Brodkey, B Kaufman, et al.
The New England Journal of Medicine|December 1, 1983
Progesterone receptors as a prognostic factor in Stage II breast cancerG M Clark, W L McGuire, C A Hubay, et al.
Surgery|October 1, 1986
The interaction of estrogen receptor status and race in predicting prognosis for stage I breast cancer patientsJ P Crowe, N H Gordon, C A Hubay, et al.
Cancer|November 1, 1989
Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancerO H Pearson, C A Hubay, N H Gordon, et al.
Surgery|October 1, 1987
Recurrence patterns in a prospective study of patients with stage II breast cancer treated with endocrine-chemotherapyJ P Crowe, N H Gordon, A R Antunez, et al.
Breast Cancer Research and Treatment|January 1, 1982
Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsJ P Crowe, C A Hubay, O H Pearson, et al.
Pageof 5